Co-Diagnostics raises ~$2.67M via warrant exercise; issues new warrants for 3.4M shares

Co-Diagnostics, Inc.

Gross proceeds of ~$2.67M from cash exercise of 1,702,362 existing warrants at $1.571/share.
New warrants to purchase up to 3,404,724 shares at $1.56/share, exercisable only after stockholder approval.
Outstanding shares to increase from 5,277,846 to 6,980,208 after the exercise.
Placement agent Maxim Group LLC receives 7% cash fee and $50,000 expense reimbursement.
Net proceeds to be used for general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.